Has Shelley Miles, APRN received payments from drug or device companies?

Yes. Drug and device makers reported $33,937 in general payments to Shelley Miles, APRN across 450 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Shelley Miles, APRN did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Shelley Miles, APRN come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Shelley Miles, APRN

Nurse Practitioner · Las Vegas, NVNPI 1265788343

Payments from drug & device makers

$33,937in general payments, 2019–2025

Across 450 payments — averaging $75.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Regeneron Healthcare Solutions, Inc.$22K
Amgen$2K
Daiichi Sankyo Inc.$2K
AstraZeneca$1K
Incyte Corporation$896
Novartis$559
plus $6K from 40 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Regeneron Healthcare Solutions, Inc.	58	$21,732
Amgen	9	$2,347
Daiichi Sankyo Inc.	123	$1,620
AstraZeneca	19	$1,123
Incyte Corporation	11	$896
Novartis	31	$559
Gilead	17	$538
Exelixis Inc.	18	$494
Johnson & Johnson	19	$440
Beigene USA, Inc.	16	$342
Bayer	7	$298
Sobi, Inc	12	$274
Merck	11	$263
AbbVie	8	$254
Astellas Pharma US Inc	7	$216
Stemline Therapeutics Inc.	9	$199
Karyopharm Therapeutics Inc.	6	$193
Beone Medicines USA, Inc.	3	$191
Bristol Myers Squibb	9	$173
Eisai Inc.	3	$146
Jazz Pharmaceuticals Inc.	2	$139
Seagen Inc.	4	$137
Blueprint Medicines Corporation	1	$122
Deciphera Pharmaceuticals Inc.	1	$119
TG Therapeutics, Inc.	1	$115
AVEO Pharmaceuticals, Inc.	2	$115
Genentech USA, Inc.	6	$110
EMD Serono, Inc.	5	$87
Agios Pharmaceuticals, Inc.	3	$64
Sanofi	3	$63
Genmab U.S., Inc.	2	$62
E.r. Squibb & Sons, L.L.C.	3	$58
Sun Pharmaceutical Industries Inc.	2	$56
Lilly USA, LLC	3	$51
Pharmacosmos Therapeutics Inc.	1	$48
Servier Pharmaceuticals LLC	2	$47
Ipsen Biopharmaceuticals, Inc	2	$44
Pfizer	2	$38
Immunogen, Inc.	1	$24
Takeda Pharmaceuticals U.S.A., Inc.	1	$22
Taiho Oncology, Inc.	1	$21
Mirati Therapeutics, Inc.	1	$20
Tersera Therapeutics LLC	1	$20
Pharmacyclics LLC, An Abbvie Company	1	$19
Rigel Pharmaceuticals, Inc.	2	$19
Sumitomo Pharma America, Inc.	1	$17

How this compares

$33,937 in reported general payments places this provider in the 95th percentile of 933 nurse practitioner providers in Nevada.

See all nurse practitioner providers in Nevada →

Medicare billing

Part B allowed, 2024

$56,763

Medicare patients

401

Services billed

2,512

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Las Vegas

Vanessa AntolinLas Vegas$225K
Shannon SouthwickLas Vegas$85K
Melanie SpeedLas Vegas$80K
Nasslynne LenzLas Vegas$32K
Bonnie KwanLas Vegas$30K
Amanda RalphLas Vegas$26K
Teodoro AgtayLas Vegas$25K
Katherine WhitmireLas Vegas$18K
Jennifer WalshLas Vegas$18K
Andrew VolinLas Vegas$17K

See the full list for Nevada →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →